These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 23085179)

  • 21. Structure-based virtual screening approach to the discovery of p38 MAP kinase inhibitors.
    Choi H; Park HJ; Shin JC; Ko HS; Lee JK; Lee S; Park H; Hong S
    Bioorg Med Chem Lett; 2012 Mar; 22(6):2195-9. PubMed ID: 22342625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of a potent, selective protein tyrosine phosphatase 1B inhibitor using a linked-fragment strategy.
    Szczepankiewicz BG; Liu G; Hajduk PJ; Abad-Zapatero C; Pei Z; Xin Z; Lubben TH; Trevillyan JM; Stashko MA; Ballaron SJ; Liang H; Huang F; Hutchins CW; Fesik SW; Jirousek MR
    J Am Chem Soc; 2003 Apr; 125(14):4087-96. PubMed ID: 12670229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of novel inhibitors of extracellular signal-regulated kinase 2 based on the structure-based virtual screening.
    Park H; Bahn YJ; Jeong DG; Woo EJ; Kwon JS; Ryu SE
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5372-6. PubMed ID: 18835158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fragment screening and assembly: a highly efficient approach to a selective and cell active protein tyrosine phosphatase 1B inhibitor.
    Liu G; Xin Z; Pei Z; Hajduk PJ; Abad-Zapatero C; Hutchins CW; Zhao H; Lubben TH; Ballaron SJ; Haasch DL; Kaszubska W; Rondinone CM; Trevillyan JM; Jirousek MR
    J Med Chem; 2003 Sep; 46(20):4232-5. PubMed ID: 13678400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of a diverse series of phosphacoumarins with biological activity.
    Li X; Zhang D; Pang H; Shen F; Fu H; Jiang Y; Zhao Y
    Org Lett; 2005 Oct; 7(22):4919-22. PubMed ID: 16235922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of novel DUSP16 phosphatase inhibitors through virtual screening with homology modeled protein structure.
    Park H; Park SY; Nam SW; Ryu SE
    J Biomol Screen; 2014 Dec; 19(10):1383-90. PubMed ID: 25245988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-based optimization of benzoic acids as inhibitors of protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase.
    Maccari R; Ottanà R; Ciurleo R; Paoli P; Manao G; Camici G; Laggner C; Langer T
    ChemMedChem; 2009 Jun; 4(6):957-62. PubMed ID: 19288492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of novel alpha-glucosidase inhibitors based on the virtual screening with the homology-modeled protein structure.
    Park H; Hwang KY; Oh KH; Kim YH; Lee JY; Kim K
    Bioorg Med Chem; 2008 Jan; 16(1):284-92. PubMed ID: 17920282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The phosphatase domains of LAR, CD45, and PTP1B: structural correlations with peptide-based inhibitors.
    Glover NR; Tracey AS
    Biochem Cell Biol; 2000; 78(1):39-50. PubMed ID: 10735562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure of the hematopoietic tyrosine phosphatase (HePTP) catalytic domain: structure of a KIM phosphatase with phosphate bound at the active site.
    Mustelin T; Tautz L; Page R
    J Mol Biol; 2005 Nov; 354(1):150-63. PubMed ID: 16226275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystal structure of ED-Eya2: insight into dual roles as a protein tyrosine phosphatase and a transcription factor.
    Jung SK; Jeong DG; Chung SJ; Kim JH; Park BC; Tonks NK; Ryu SE; Kim SJ
    FASEB J; 2010 Feb; 24(2):560-9. PubMed ID: 19858093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-assisted discovery of Variola major H1 phosphatase inhibitors.
    Phan J; Tropea JE; Waugh DS
    Acta Crystallogr D Biol Crystallogr; 2007 Jun; 63(Pt 6):698-704. PubMed ID: 17505108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The structural basis for the selectivity of benzotriazole inhibitors of PTP1B.
    Scapin G; Patel SB; Becker JW; Wang Q; Desponts C; Waddleton D; Skorey K; Cromlish W; Bayly C; Therien M; Gauthier JY; Li CS; Lau CK; Ramachandran C; Kennedy BP; Asante-Appiah E
    Biochemistry; 2003 Oct; 42(39):11451-9. PubMed ID: 14516196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, activity and molecular modeling of a new series of chromones as low molecular weight protein tyrosine phosphatase inhibitors.
    Forghieri M; Laggner C; Paoli P; Langer T; Manao G; Camici G; Bondioli L; Prati F; Costantino L
    Bioorg Med Chem; 2009 Apr; 17(7):2658-72. PubMed ID: 19297174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystal structures and inhibitor identification for PTPN5, PTPRR and PTPN7: a family of human MAPK-specific protein tyrosine phosphatases.
    Eswaran J; von Kries JP; Marsden B; Longman E; Debreczeni JE; Ugochukwu E; Turnbull A; Lee WH; Knapp S; Barr AJ
    Biochem J; 2006 May; 395(3):483-91. PubMed ID: 16441242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of MEK/PI3K dual inhibitor via structure-based virtual screening.
    Park H; Lee S; Hong S
    Bioorg Med Chem Lett; 2012 Aug; 22(15):4946-50. PubMed ID: 22771009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In silico structure-based design of a potent and selective small peptide inhibitor of protein tyrosine phosphatase 1B, a novel therapeutic target for obesity and type 2 diabetes mellitus: a computer modeling approach.
    Rao GS; Ramachandran MV; Bajaj JS
    J Biomol Struct Dyn; 2006 Feb; 23(4):377-84. PubMed ID: 16363874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitors of protein tyrosine phosphatases: next-generation drugs?
    Bialy L; Waldmann H
    Angew Chem Int Ed Engl; 2005 Jun; 44(25):3814-39. PubMed ID: 15900534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Engineering the catalytic domain of human protein tyrosine phosphatase beta for structure-based drug discovery.
    Evdokimov AG; Pokross M; Walter R; Mekel M; Cox B; Li C; Bechard R; Genbauffe F; Andrews R; Diven C; Howard B; Rastogi V; Gray J; Maier M; Peters KG
    Acta Crystallogr D Biol Crystallogr; 2006 Dec; 62(Pt 12):1435-45. PubMed ID: 17139078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-based virtual screening approach to the discovery of novel inhibitors of factor-inhibiting HIF-1: identification of new chelating groups for the active-site ferrous ion.
    Ko S; Lee MK; Shin D; Park H
    Bioorg Med Chem; 2009 Nov; 17(22):7769-74. PubMed ID: 19822432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.